Literature DB >> 7304459

Congenital complete atrioventricular block: clinical and electrophysiologic predictors of need for pacemaker insertion.

P P Karpawich, P C Gillette, A Garson, P S Hesslein, C B Porter, D G McNamara.   

Abstract

Because of initial Adams-Stokes attack in the patient with congenital complete atrioventricular (A-V) block may sometimes prove fatal, there is a need to be able to identify the patient at great risk of having such attacks. Twenty-four children with congenital complete A-V block were followed up for 1 to 19 years to determine the efficacy of current methods of predicting risk for Adams-Stokes syncope and the usefulness of pacemaker therapy in relieving symptoms. The heart rate at rest, configuration of surface electrocardiographic complexes, data obtained during intracardiac electrophysiologic study and response to graded treadmill exercise testing were compared in children with and without syncope. One or more Adams-Stokes episodes were experienced by eight children, one of whom died. Only a persistent heart rate at rest of 50 beats/min or less demonstrated any significant (probability [p] less than 0.01) correlation with the incidence of syncope. Intracardiac electrophysiologic study was of little benefit because of site of block did not correlate with syncope. Although the increase in heart rate during treadmill exercise testing showed no correlation with prevalence of syncope or location of block, exercise-induced ventricular ectopic beats may have predictive value in older children and young adults. Ventricular pacemakers were implanted in 10 children. Each child was asymptomatic over a 1 to 10 year follow-up period. Because extreme bradycardia may contribute to the prevalence of Adams- Stokes attacks in children with congenital complete A-V block, careful evaluation of heart rate at rest may be an effective means of differentiating patients at risk of syncope. Pacemaker therapy is a feasible and effective method of treatment in young children and relieves symptoms

Entities:  

Mesh:

Year:  1981        PMID: 7304459     DOI: 10.1016/0002-9149(81)90326-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Congenital complete atrioventricular block.

Authors:  N J Kertesz; A L Fenrich; R A Friedman
Journal:  Tex Heart Inst J       Date:  1997

2.  Fatal heart block due to mesothelioma of the atrioventricular node.

Authors:  D W Evans; P G Stovin
Journal:  Br Heart J       Date:  1986-12

Review 3.  Advances in the treatment of cardiac dysrhythmias.

Authors:  P C Gillette; B A Ross; F Crawford; V Zeigler; A Zinner
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

Review 4.  Cardiac dysrhythmias in pediatric intensive care.

Authors:  M L Falterman
Journal:  Indian J Pediatr       Date:  1993 May-Jun       Impact factor: 1.967

5.  Congenital complete heart block.

Authors:  S M Cobbe
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-04

Review 6.  Congenital complete heart block: an overview.

Authors:  J C Mohan; K S Reddy
Journal:  Indian J Pediatr       Date:  1983 Nov-Dec       Impact factor: 1.967

7.  An experience with permanent cardiac pacing in children and adolescents.

Authors:  U Kaul; J C Mohan; S Shrivastava; P Venugopal; M L Bhatia
Journal:  Indian J Pediatr       Date:  1983 Nov-Dec       Impact factor: 1.967

8.  Outcome of isolated congenital complete heart block diagnosed in utero.

Authors:  A M Groves; L D Allan; E Rosenthal
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

9.  Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristics.

Authors:  L Bergfeldt; H Vallin; O Edhag
Journal:  Br Heart J       Date:  1984-02

10.  Ambulatory arrhythmia screening in symptomatic children and young adults: comparative effectiveness of Holter and telephone event recordings.

Authors:  P P Karpawich; D L Cavitt; J S Sugalski
Journal:  Pediatr Cardiol       Date:  1993-07       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.